1. Home
  2. UP vs CNTB Comparison

UP vs CNTB Comparison

Compare UP & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

HOLD

Current Price

$1.71

Market Cap

134.2M

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$0.59

Market Cap

140.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UP
CNTB
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.2M
140.4M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
UP
CNTB
Price
$1.71
$0.59
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $5.71
AVG Volume (30 Days)
98.7K
★ 569.3K
Earning Date
11-05-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.29
N/A
EPS
N/A
★ N/A
Revenue
★ $736,495,000.00
$64,000.00
Revenue This Year
$193.34
$7,473.67
Revenue Next Year
$12.65
$240.46
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.36
$0.55
52 Week High
$10.09
$3.82

Technical Indicators

Market Signals
Indicator
UP
CNTB
Relative Strength Index (RSI) 24.18 34.22
Support Level $0.45 N/A
Resistance Level $4.01 $2.62
Average True Range (ATR) 0.28 0.07
MACD -0.09 0.01
Stochastic Oscillator 11.27 16.72

Price Performance

Historical Comparison
UP
CNTB

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation. The company offers a private aviation solution with a large and diverse aircraft fleet, delivered through a mix of charter solutions and its membership program that utilizes its controlled aircraft fleet and a network of safety-vetted charter operators. Through its partnership firm, it provides members and customers with an offering across private and premium commercial travel. It generates the majority of its revenue from member and customer flights through its membership program and charter solutions, as well as from membership fees and other activities and services, including group charter flights, cargo flights, and special missions. Geographically, the company generates maximum revenue from the United States.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: